ANI Pharmaceuticals, Inc. (ANIP)

NGM – Real Time Price. Currency in USD

84.50

+1.22 (1.46%)

At close: Jun 26, 2026, 4:00 PM EDT

85.00

+0.50 (0.59%)

After-hours: Jun 26, 2026, 7:18 PM EDT

16.06.2026

Here's Why ANI Pharmaceuticals (ANIP) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

15.06.2026

20 growth stocks priced as value stocks

A broad screen of U.S. stocks yields a list of companies trading at low valuations to expected earnings, with high projected revenue growth rates through 2028. The list of 20 stocks includes eight financial services companies, five healthcare names and four in the information technology sector.

10.06.2026

Should You Buy ANI Pharmaceuticals at 9.8x Forward Earnings?

ANIP trades at 9.75x forward earnings after raising 2026 guidance, but investors must weigh Cortrophin-led growth against competition and customer concentration.

10.06.2026

ANI Pharmaceuticals Targets Acute Gout With Cortrophin Push

ANIP expands Cortrophin into acute gout flares with a 90-person sales force as investors watch adoption, spending and 2026 milestones.

10.06.2026

ANIP Pharmaceuticals' Cortrophin Gel Drives 2026 Growth

ANI Pharmaceuticals ANIP is reshaping its growth profile. In 2025, revenue surged on the back of a rare disease franchise that is becoming the company's defining investment narrative.

29.05.2026

Why ANI Pharmaceuticals (ANIP) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

27.05.2026

ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference

PRINCETON, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that Nikhil Lalwani, Chief Executive Officer, will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference as follows:

Videos

No Data

There is no data to display

Press releases

08.05.2026

ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

PRINCETON, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced financial results and business highlights for the first quarter ended March 31, 2026.

ANI Pharmaceuticals, Inc. (ANIP)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

ANI Pharmaceuticals, Inc. (ANIP)

Here's Why ANI Pharmaceuticals (ANIP) is a Strong Growth Stock

20 growth stocks priced as value stocks

Should You Buy ANI Pharmaceuticals at 9.8x Forward Earnings?

ANI Pharmaceuticals Targets Acute Gout With Cortrophin Push

ANIP Pharmaceuticals' Cortrophin Gel Drives 2026 Growth

Why ANI Pharmaceuticals (ANIP) is a Top Growth Stock for the Long-Term

ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference

Videos

No Data

Press releases

ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

Here's Why ANI Pharmaceuticals (ANIP) is a Strong Growth Stock

20 growth stocks priced as value stocks

Should You Buy ANI Pharmaceuticals at 9.8x Forward Earnings?

ANI Pharmaceuticals Targets Acute Gout With Cortrophin Push

ANIP Pharmaceuticals' Cortrophin Gel Drives 2026 Growth

Why ANI Pharmaceuticals (ANIP) is a Top Growth Stock for the Long-Term

ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference

Videos

No Data

Press releases

ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity

ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules

ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet

Search stocks

ANI Pharmaceuticals, Inc. (ANIP)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

ANI Pharmaceuticals, Inc. (ANIP)

Here's Why ANI Pharmaceuticals (ANIP) is a Strong Growth Stock

20 growth stocks priced as value stocks

Should You Buy ANI Pharmaceuticals at 9.8x Forward Earnings?

ANI Pharmaceuticals Targets Acute Gout With Cortrophin Push

ANIP Pharmaceuticals' Cortrophin Gel Drives 2026 Growth

Why ANI Pharmaceuticals (ANIP) is a Top Growth Stock for the Long-Term

ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference

Videos

No Data

Press releases

ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

Here's Why ANI Pharmaceuticals (ANIP) is a Strong Growth Stock

20 growth stocks priced as value stocks

Should You Buy ANI Pharmaceuticals at 9.8x Forward Earnings?

ANI Pharmaceuticals Targets Acute Gout With Cortrophin Push

ANIP Pharmaceuticals' Cortrophin Gel Drives 2026 Growth

Why ANI Pharmaceuticals (ANIP) is a Top Growth Stock for the Long-Term

ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference

Videos

No Data

Press releases

ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity

ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules

ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet